Cited 82 times in
Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이병인 | - |
dc.date.accessioned | 2015-05-19T17:29:18Z | - |
dc.date.available | 2015-05-19T17:29:18Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1525-5050 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/108241 | - |
dc.description.abstract | This study was a prospective, randomized, open-label investigation of the long-term effects of zonisamide (ZNS) monotherapy on cognition and mood of patients with epilepsy. Forty-three patients with epilepsy received ZNS, with final dose groups of 100, 200, 300, and 400mg/day. Cognitive and mood tests were done twice, at baseline and 1 year after starting medication. Nine patients were withdrawn prior to their follow-up tests. Three patients (33%) dropped out during the titration period because of cognitive and mood problems. Thirty-four patients completed follow-up neuropsychological tests. After 1 year of treatment, 16 patients (47%) complained of cognitive deficits. Only 5 patients (15%) experienced mood changes. Although ZNS decreased seizure frequency and EEG abnormalities and did not elicit significant mood changes, it had negative effects on several cognitive tests. Worse performance on delayed word recall, Trail Making Test Part B, and verbal fluency was related to dose. In conclusion, ZNS has adverse effects on cognition even after 1 year of treatment. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 102~108 | - |
dc.relation.isPartOf | EPILEPSY & BEHAVIOR | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Affect/drug effects* | - |
dc.subject.MESH | Anticonvulsants/therapeutic use* | - |
dc.subject.MESH | Cognition/drug effects* | - |
dc.subject.MESH | Dose-Response Relationship, Drug | - |
dc.subject.MESH | Electroencephalography | - |
dc.subject.MESH | Epilepsy/drug therapy* | - |
dc.subject.MESH | Epilepsy/psychology* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Isoxazoles/therapeutic use* | - |
dc.subject.MESH | Longitudinal Studies | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Neuropsychological Tests | - |
dc.subject.MESH | Prospective Studies | - |
dc.subject.MESH | Zonisamide | - |
dc.title | Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Neurology (신경과학) | - |
dc.contributor.googleauthor | Sung-Pa Park | - |
dc.contributor.googleauthor | Yang-Ha Hwang | - |
dc.contributor.googleauthor | Ho-Won Lee | - |
dc.contributor.googleauthor | Chung-Kyu Suh | - |
dc.contributor.googleauthor | Soon-Hak Kwon | - |
dc.contributor.googleauthor | Byung-In Lee | - |
dc.identifier.doi | 10.1016/j.yebeh.2007.08.002 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02797 | - |
dc.relation.journalcode | J00794 | - |
dc.identifier.eissn | 1525-5069 | - |
dc.identifier.pmid | 17945539 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S1525505007002752 | - |
dc.subject.keyword | Zonisamide | - |
dc.subject.keyword | Cognition | - |
dc.subject.keyword | Mood | - |
dc.subject.keyword | Adverse effects | - |
dc.subject.keyword | Epilepsy | - |
dc.contributor.alternativeName | Lee, Byung In | - |
dc.contributor.affiliatedAuthor | Lee, Byung In | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 12 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 102 | - |
dc.citation.endPage | 108 | - |
dc.identifier.bibliographicCitation | EPILEPSY & BEHAVIOR, Vol.12(1) : 102-108, 2008 | - |
dc.identifier.rimsid | 35276 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.